Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells

Ken Takezawa, Isamu Okamoto, Kimio Yonesaka, Erina Hatashita, Yuki Yamada, Masahiro Fukuoka, Kazuhiko Nakagawa

Research output: Contribution to journalArticlepeer-review

65 Citations (Scopus)

Fingerprint Dive into the research topics of 'Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells'. Together they form a unique fingerprint.

Medicine & Life Sciences